Survival analysis of laparoscopic and laparotomy hepatectomy for pediatric liver neoplasm: a single-center retrospective cohort study
Frontiers in Pediatrics · 23.07.2026 · 14
DOI: 10.3389/fped.2026.1892867 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Frontiers in Pediatrics, online erschienen am 23.07.2026. Verfasst von Shan Huang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
To evaluate the efficacy and postoperative survival following laparoscopic and laparotomy hepatectomy of pediatric liver neoplasm (PLN).
Methods
A retrospective analysis was conducted on 180 patients who underwent hepatectomy of PLN in our center between January 2014 and May 2025. Demographic information, perioperative clinical data, postoperative liver function recovery, complications, and survival outcomes were collected to evaluate the efficacy, postoperative complications, and survival rates after laparoscopic and laparotomy hepatectomy of PLN.
Results
In this study, 89 patients (49.44%) were male and 91 (50.56%) were female. The median age at surgery was 5.7 years. 66 patients (36.67%) were diagnosed with benign liver neoplasms (BLN), and 114 patients (63.33%) with malignant liver neoplasms (MLN). Laparoscopy was performed in 83 patients (46.11%), while laparotomy was performed in 97 patients (53.89%). In the BLN group, there were no significant differences between the laparoscopic and laparotomy groups in terms of postoperative liver function recovery or complication rates. The postoperative survival rate was 100% in both groups. However, the length of hospital stay was significantly shorter in the laparoscopic group ( P < 0.001). In the MLN group, there were no significant differences in postoperative liver function recovery or complication rates between the two surgical approaches. However, the laparoscopic group had a significantly longer operative time ( P = 0.009), more frequent Pringle maneuver ( P < 0.001). The 5-year cumulative survival rate was 78.13% in the laparoscopic group and 81.23% in the laparotomy group, with no significant difference between the two approaches ( P = 0.732).
Conclusion
Surgical treatment for PLN yields favorable outcomes. Laparoscopy is recommended for BLN or MLN with localized lesions. However, for large MLN that encase vessels or show diffuse infiltration, laparotomy is recommended.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Nephrology, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China.
- School of Clinical Medicine, The First Affiliated Hospital of Chengdu Medical College, Chengdu, China.
- Department of Pediatric Surgery, West China Hospital, Sichuan University, Chengdu, China.
- Department of Liver Transplantation Center, West China Hospital, Sichuan University, Chengdu, China.
Zitieren
APA
Huang, S., Yang, Q., Xie, Z., Chen, Y., Peng, Y., Luo, C., Song, J., & Yang, J. (2026). Survival analysis of laparoscopic and laparotomy hepatectomy for pediatric liver neoplasm: a single-center retrospective cohort study. Frontiers in Pediatrics, 14. https://doi.org/10.3389/fped.2026.1892867
Vancouver
Huang S, Yang Q, Xie Z, Chen Y, Peng Y, Luo C, et al. Survival analysis of laparoscopic and laparotomy hepatectomy for pediatric liver neoplasm: a single-center retrospective cohort study. Frontiers in Pediatrics. 2026;14. doi:10.3389/fped.2026.1892867
BibTeX
@article{Huang2026,
author = {Huang, Shan and Yang, Qianwei and Xie, Zhenyu and Chen, Yang and Peng, Yun and Luo, Chengkun and Song, Jiulin and Yang, Jian},
title = {Survival analysis of laparoscopic and laparotomy hepatectomy for pediatric liver neoplasm: a single-center retrospective cohort study},
journal = {Frontiers in Pediatrics},
year = {2026},
volume = {14},
doi = {10.3389/fped.2026.1892867}
}
EUVIMED